19 Jun 2025
Introduction In the rapidly evolving landscape of Canadian healthcare, biosimilars are emerging as a game-changing solution to rising medical costs. With the total biologics market valued at $8 billion and biosimilars representing $1 billion, these innovative medications are reshaping how …...
19 Jun 2025
Executive Summary: Comprehensive exploration of data linkage methodologies Critical analysis of current challenges and innovative solutions Strategic recommendations for healthcare researchers and policymakers Introduction Data linkage represents a transformative approach in healthcare research, enabling comprehensive insights by connecting disparate information …...
18 Jun 2025
32min 29sec
Join leading experts from Roche, University of Toronto, and industry as they dive deep into the future of real-world evidence (RWE). Discover how Canada can become a global leader in pharmaceutical data, learn about critical challenges in RWE implementation, and …...
18 Jun 2025
44min 59sec
Dive into the world of biosimilars with leading Canadian healthcare experts! This panel discussion explores the evolution of biosimilar adoption, patient access challenges, healthcare stakeholder perspectives, and the future of innovative medical treatments. Learn about cost savings, patient support programs, …...
17 Jun 2025
47min 49sec
Join leading experts from Christine Donaldson of Health Pro Canada, Kristin Willemsen of Canadian Generic Pharmaceutical Association, Shanzeh Choudhry of University of Toronto, and Dr. Alexandra Wright of SCANH Health as they discuss critical strategies to manage and mitigate drug …...
09 Jun 2025
29min 36sec
Discover how the National Institute for Health and Care Excellence (NICE) is revolutionizing healthcare technology assessment. In this exclusive presentation, Kendall from NICE reveals key strategies for faster, more efficient medical evaluations, international collaboration, and improving patient access to innovative …...
09 Jun 2025
Executive Summary The Patented Medicines Prices Review Board (PMPRB) is undergoing a significant transformation in its approach to pharmaceutical pricing guidelines. This white paper explores the comprehensive consultation process that is reshaping the organization’s methodology for monitoring and reviewing drug …...
05 Jun 2025
38min 21sec
Dive deep into the Patented Medicines Prices Review Board’s new guidelines with Guillaume Couillard, of PMPRB. Learn about key changes in price monitoring, stakeholder engagement, and how these updates will impact pharmaceutical companies in Canada. Discover the PMPRB’s evolving mandate, …...
05 Jun 2025
47min 43sec
Dive deep into the complex world of Preferred Pharmacy Networks (PPNs) with industry experts Stephanie Babbitt of Sanofi, Sandra Hanna of NPAC, and Bruce Winston of Neighbourhood Pharmacy. Hear about key challenges and opportunities from pharmacy, pharmaceutical manufacturing, and patient …...
Loading...
